Theravance Biopharma (TBPH) Net Equity Issued and Repurchased (2015 - 2025)

Theravance Biopharma (TBPH) posted quarterly Net Equity Issued and Repurchased of $20000.0 for Q1 2025, down 33.33% quarter-over-quarter from $30000.0 in Q4 2024.

Theravance Biopharma (TBPH) Net Equity Issued and Repurchased (2015 - 2025) Analysis & Trends

Theravance Biopharma (TBPH) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $20000.0 the latest figure, recorded in Q1 2025.

  • In Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $20000.0; the TTM figure through Dec 2025 stood at $20000.0 (down 63.64% YoY), while the FY2025 annual figure was $20000.0, down 79.8% from the prior year.
  • Net Equity Issued and Repurchased declined to $20000.0 in Q1 2025 per TBPH's latest filing, from $30000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $30000.0 in Q4 2024 and bottomed at $20000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Theravance Biopharma 880.59 Mn 492.93 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 20,000.00
Mar 31, 2025 20,000.00
Dec 31, 2024 30,000.00
Dec 31, 2024 30,000.00
Sep 30, 2024 25,000.00
Sep 30, 2024 25,000.00
Mar 31, 2020 139.92 Mn
Mar 31, 2020 139.92 Mn
Dec 31, 2016 107.79 Mn
Dec 31, 2016 107.79 Mn
Sep 30, 2016 17,000.00
Sep 30, 2016 17,000.00
Jun 30, 2016 117.42 Mn
Jun 30, 2016 117.42 Mn
Mar 31, 2016 27.80 Mn
Mar 31, 2016 27.80 Mn
Dec 31, 2015 51.76 Mn
Dec 31, 2015 51.76 Mn
Sep 30, 2015 -48,000.00
Sep 30, 2015 -48,000.00